跳至主要内容
临床试验/JPRN-UMIN000030456
JPRN-UMIN000030456招募中未知

Study on drug blood concentration, effectiveness, safety, and drug tolerance using residual samples of permission system and notification type antimicrobial drug - Specific antibacterial drug residual sample PK PD study

Keio University Hospital0 个研究点目标入组 3,250 人开始时间: 2018年1月10日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
3,250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.subject licensing system and notification system Patients with a history of allergy to antibiotic drugs 2.Patients who are clinically judged to be unlikely to expect the efficacy of this drug in infections caused by this drug insensitive pathogen or resistant strain 3.Other patients judged inappropriate as subject of this study

研究者

相似试验